Near‐Infrared Light‐Mediated Cyclodextrin Metal–Organic Frameworks for Synergistic Antibacterial and Anti‐Biofilm Therapies

Yaping He,Xuanzong Wang,Chi Zhang,Junkui Sun,Jianzhong Xu,Daifeng Li
DOI: https://doi.org/10.1002/smll.202300199
IF: 13.3
2023-05-10
Small
Abstract:A controllable antibacterial Ag@MOF@PDA is constructed by functionalizing cyclodextrin metal–organic frameworks with polydopamine (PDA) and ultrafine Ag NPs. The PDA coating enables its long‐term bactericidal capability by gradual releasing of Ag+, and NIR‐mediated hyperthermia can accelerate its release rate, which realizes a synergistic chemical‐photothermal capacity to combat bacteria and biofilm infections, representing a potential antibiotic‐free alternative in the "post‐antibiotic era." Bacterial infections pose a significant threat to global public health; therefore, the development of novel therapeutics is urgently needed. Herein, a controllable antibacterial nanoplatform utilizing cyclodextrin metal–organic frameworks (CD‐MOFs) as a template to synthesize ultrafine silver nanoparticles (Ag NPs) in their porous structure is constructed. Subsequently, polydopamine (PDA) is encapsulated on the CD‐MOFs' surface via dopamine polymerization to enhance the water stability and enable hyperthermia capacity. The resulting Ag@MOF@PDA generates localized hyperthermia and gradually releases Ag+ to achieve long‐term photothermal‐chemical bactericidal capability. The release rate of Ag+ can be accelerated by NIR‐mediated heating in a controllable manner, quickly reaching the effective concentration and reducing the frequency of medication to avoid potential toxicity. In vitro experiments demonstrate that the combined antibacterial strategy can not only effectively kill both gram‐negative and gram‐positive bacteria, but also directly eradicate mature biofilms. In vivo results confirm that both bacterial‐ and biofilm‐infected wounds treated with a combination of Ag@MOF@PDA and laser exhibit satisfactory recovery with minimal toxicity, displaying a superior therapeutic effect compared to other groups. Together, the results warrant that the Ag@MOF@PDA realizes synergistic antibacterial capacity and controllable release of Ag+ to combat bacterial and biofilm infections, providing a potential antibiotic‐free alternative in the "post‐antibiotic era."
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?
This paper aims to address the significant threat that bacterial infections pose to global public health, especially drug - resistant bacterial infections and the formation of mature biofilms due to antibiotic abuse. Therefore, a controllable antibacterial nano - platform was developed. Ultra - fine silver nanoparticles (AgNPs) were synthesized using cyclodextrin - based metal - organic frameworks (CD - MOFs) as templates, and polydopamine (PDA) was encapsulated in their porous structures to enhance water stability and achieve photothermal capabilities. The constructed Ag@MOF@PDA achieved long - term photothermal - chemical sterilization capabilities through local photothermal effects and the gradual release of Ag⁺ ions. In addition, near - infrared (NIR) - mediated heating can accelerate the release rate of Ag⁺, quickly reach an effective concentration, reduce the frequency of drug use, and avoid potential toxicity. In vitro experiments have shown that this combined antibacterial strategy can not only effectively kill Gram - negative and positive bacteria, but also directly eradicate mature biofilms. In vivo results have confirmed that the use of Ag@MOF@PDA combined with laser treatment for bacterial and biofilm - infected wounds shows satisfactory recovery effects with minimal toxicity, demonstrating a more superior treatment effect than other groups. Overall, these results indicate that Ag@MOF@PDA achieves synergistic antibacterial capabilities and controllable release of Ag⁺, providing a potential antibiotic - free alternative for combating bacterial and biofilm infections, especially in the "post - antibiotic era".